Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals

Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes & metabolism 2015-04, Vol.41 (2), p.126-131
Hauptverfasser: Liatis, S, Mylona, M, Kalopita, S, Papazafiropoulou, A, Karamagkiolis, S, Melidonis, A, Xilomenos, A, Ioannidis, I, Kaltsas, G, Lanaras, L, Papas, S, Basagiannis, C, Kokkinos, A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 131
container_issue 2
container_start_page 126
container_title Diabetes & metabolism
container_volume 41
creator Liatis, S
Mylona, M
Kalopita, S
Papazafiropoulou, A
Karamagkiolis, S
Melidonis, A
Xilomenos, A
Ioannidis, I
Kaltsas, G
Lanaras, L
Papas, S
Basagiannis, C
Kokkinos, A
description Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Methods Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients’ diabetes clinics of the same hospitals during the same time period. Results Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7 ± 10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7 ± 18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20–1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5–6.36]), use of insulin (OR: 2.35 [1.42–3.95]), lower estimated GFR (OR: 1.15 [1.07–1.23] at 10 mL/min) and number of comorbidities (OR: 1.74 [1.34–2.27]) were each independently associated with hypoglycaemia requiring medical assistance. Conclusion Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas.
doi_str_mv 10.1016/j.diabet.2014.10.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1673078915</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1262363614001670</els_id><sourcerecordid>1673078915</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-f62b12b4bcea38db5909b7b3841e2350036580f6b442046a4cc5aa4b40a3bb4c3</originalsourceid><addsrcrecordid>eNqFkctuFDEQRS1ERELgDxDykk0PfrXbwwIpioAgRWKRsLZsT03ioV-x3RO1xMenWh1YsGFVpdKt17mEvONswxnXHw-bXXQeykYwrrC0YUy_IGfcNKbijWEvMRdaVFJLfUpe53xgjIutNK_IqaiVNkrpM_L7ah6Hu3YODrroaIKHKabY39EOdjG4lrqcYy6uD0BjT0dXIvQl08dY7ul6AORP9IKOacgjhBKPQLupLTGgLgHNUzrCvPQWSCW6NNN7VMbi2vyGnOwxwNvneE5-fv1ye3lVXf_49v3y4roKyjSl2mvhufDKB3DS7Hy9ZVvfeGkUByFrxqSuDdtrr5RgSjsVQu2c8oo56b0K8px8WOfikQ8T5GK7mAO0rethmLLlupGsMVteo1St0oD_5AR7O6bY4dWWM7twtwe7vm0X7ksVuWPb--cNk0dyf5v-gEbB51UA-OcxQrI5IMmAlBNSs7sh_m_DvwNCG_vFol8wQz4MU-qRoeU2C8vszeL9Yj1XaLtumHwCS56tcA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1673078915</pqid></control><display><type>article</type><title>Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Liatis, S ; Mylona, M ; Kalopita, S ; Papazafiropoulou, A ; Karamagkiolis, S ; Melidonis, A ; Xilomenos, A ; Ioannidis, I ; Kaltsas, G ; Lanaras, L ; Papas, S ; Basagiannis, C ; Kokkinos, A</creator><creatorcontrib>Liatis, S ; Mylona, M ; Kalopita, S ; Papazafiropoulou, A ; Karamagkiolis, S ; Melidonis, A ; Xilomenos, A ; Ioannidis, I ; Kaltsas, G ; Lanaras, L ; Papas, S ; Basagiannis, C ; Kokkinos, A</creatorcontrib><description>Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Methods Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients’ diabetes clinics of the same hospitals during the same time period. Results Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7 ± 10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7 ± 18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20–1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5–6.36]), use of insulin (OR: 2.35 [1.42–3.95]), lower estimated GFR (OR: 1.15 [1.07–1.23] at 10 mL/min) and number of comorbidities (OR: 1.74 [1.34–2.27]) were each independently associated with hypoglycaemia requiring medical assistance. Conclusion Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas.</description><identifier>ISSN: 1262-3636</identifier><identifier>EISSN: 1878-1780</identifier><identifier>DOI: 10.1016/j.diabet.2014.10.006</identifier><identifier>PMID: 25468446</identifier><language>eng</language><publisher>France: Elsevier Masson SAS</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Diabetes Mellitus, Type 1 - drug therapy ; Diabetes Mellitus, Type 2 - drug therapy ; Endocrinology &amp; Metabolism ; Female ; Hospitalization ; Humans ; Hypoglycaemia ; Hypoglycemia - chemically induced ; Hypoglycemia - epidemiology ; Hypoglycemia - therapy ; Hypoglycemic Agents - adverse effects ; Hypoglycemic Agents - therapeutic use ; Insulin - adverse effects ; Insulin - therapeutic use ; Internal Medicine ; Male ; Middle Aged ; Prevalence ; Prospective Studies ; Sulfonylurea Compounds - adverse effects ; Sulfonylurea Compounds - therapeutic use ; Tertiary Care Centers ; Type 1 diabetes ; Type 2 diabetes ; Young Adult</subject><ispartof>Diabetes &amp; metabolism, 2015-04, Vol.41 (2), p.126-131</ispartof><rights>Elsevier Masson SAS</rights><rights>2014 Elsevier Masson SAS</rights><rights>Copyright © 2014 Elsevier Masson SAS. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-f62b12b4bcea38db5909b7b3841e2350036580f6b442046a4cc5aa4b40a3bb4c3</citedby><cites>FETCH-LOGICAL-c487t-f62b12b4bcea38db5909b7b3841e2350036580f6b442046a4cc5aa4b40a3bb4c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1262363614001670$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25468446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liatis, S</creatorcontrib><creatorcontrib>Mylona, M</creatorcontrib><creatorcontrib>Kalopita, S</creatorcontrib><creatorcontrib>Papazafiropoulou, A</creatorcontrib><creatorcontrib>Karamagkiolis, S</creatorcontrib><creatorcontrib>Melidonis, A</creatorcontrib><creatorcontrib>Xilomenos, A</creatorcontrib><creatorcontrib>Ioannidis, I</creatorcontrib><creatorcontrib>Kaltsas, G</creatorcontrib><creatorcontrib>Lanaras, L</creatorcontrib><creatorcontrib>Papas, S</creatorcontrib><creatorcontrib>Basagiannis, C</creatorcontrib><creatorcontrib>Kokkinos, A</creatorcontrib><title>Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals</title><title>Diabetes &amp; metabolism</title><addtitle>Diabetes Metab</addtitle><description>Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Methods Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients’ diabetes clinics of the same hospitals during the same time period. Results Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7 ± 10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7 ± 18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20–1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5–6.36]), use of insulin (OR: 2.35 [1.42–3.95]), lower estimated GFR (OR: 1.15 [1.07–1.23] at 10 mL/min) and number of comorbidities (OR: 1.74 [1.34–2.27]) were each independently associated with hypoglycaemia requiring medical assistance. Conclusion Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Endocrinology &amp; Metabolism</subject><subject>Female</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Hypoglycaemia</subject><subject>Hypoglycemia - chemically induced</subject><subject>Hypoglycemia - epidemiology</subject><subject>Hypoglycemia - therapy</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Insulin - adverse effects</subject><subject>Insulin - therapeutic use</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prevalence</subject><subject>Prospective Studies</subject><subject>Sulfonylurea Compounds - adverse effects</subject><subject>Sulfonylurea Compounds - therapeutic use</subject><subject>Tertiary Care Centers</subject><subject>Type 1 diabetes</subject><subject>Type 2 diabetes</subject><subject>Young Adult</subject><issn>1262-3636</issn><issn>1878-1780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkctuFDEQRS1ERELgDxDykk0PfrXbwwIpioAgRWKRsLZsT03ioV-x3RO1xMenWh1YsGFVpdKt17mEvONswxnXHw-bXXQeykYwrrC0YUy_IGfcNKbijWEvMRdaVFJLfUpe53xgjIutNK_IqaiVNkrpM_L7ah6Hu3YODrroaIKHKabY39EOdjG4lrqcYy6uD0BjT0dXIvQl08dY7ul6AORP9IKOacgjhBKPQLupLTGgLgHNUzrCvPQWSCW6NNN7VMbi2vyGnOwxwNvneE5-fv1ye3lVXf_49v3y4roKyjSl2mvhufDKB3DS7Hy9ZVvfeGkUByFrxqSuDdtrr5RgSjsVQu2c8oo56b0K8px8WOfikQ8T5GK7mAO0rethmLLlupGsMVteo1St0oD_5AR7O6bY4dWWM7twtwe7vm0X7ksVuWPb--cNk0dyf5v-gEbB51UA-OcxQrI5IMmAlBNSs7sh_m_DvwNCG_vFol8wQz4MU-qRoeU2C8vszeL9Yj1XaLtumHwCS56tcA</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Liatis, S</creator><creator>Mylona, M</creator><creator>Kalopita, S</creator><creator>Papazafiropoulou, A</creator><creator>Karamagkiolis, S</creator><creator>Melidonis, A</creator><creator>Xilomenos, A</creator><creator>Ioannidis, I</creator><creator>Kaltsas, G</creator><creator>Lanaras, L</creator><creator>Papas, S</creator><creator>Basagiannis, C</creator><creator>Kokkinos, A</creator><general>Elsevier Masson SAS</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals</title><author>Liatis, S ; Mylona, M ; Kalopita, S ; Papazafiropoulou, A ; Karamagkiolis, S ; Melidonis, A ; Xilomenos, A ; Ioannidis, I ; Kaltsas, G ; Lanaras, L ; Papas, S ; Basagiannis, C ; Kokkinos, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-f62b12b4bcea38db5909b7b3841e2350036580f6b442046a4cc5aa4b40a3bb4c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Endocrinology &amp; Metabolism</topic><topic>Female</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Hypoglycaemia</topic><topic>Hypoglycemia - chemically induced</topic><topic>Hypoglycemia - epidemiology</topic><topic>Hypoglycemia - therapy</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Insulin - adverse effects</topic><topic>Insulin - therapeutic use</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prevalence</topic><topic>Prospective Studies</topic><topic>Sulfonylurea Compounds - adverse effects</topic><topic>Sulfonylurea Compounds - therapeutic use</topic><topic>Tertiary Care Centers</topic><topic>Type 1 diabetes</topic><topic>Type 2 diabetes</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liatis, S</creatorcontrib><creatorcontrib>Mylona, M</creatorcontrib><creatorcontrib>Kalopita, S</creatorcontrib><creatorcontrib>Papazafiropoulou, A</creatorcontrib><creatorcontrib>Karamagkiolis, S</creatorcontrib><creatorcontrib>Melidonis, A</creatorcontrib><creatorcontrib>Xilomenos, A</creatorcontrib><creatorcontrib>Ioannidis, I</creatorcontrib><creatorcontrib>Kaltsas, G</creatorcontrib><creatorcontrib>Lanaras, L</creatorcontrib><creatorcontrib>Papas, S</creatorcontrib><creatorcontrib>Basagiannis, C</creatorcontrib><creatorcontrib>Kokkinos, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes &amp; metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liatis, S</au><au>Mylona, M</au><au>Kalopita, S</au><au>Papazafiropoulou, A</au><au>Karamagkiolis, S</au><au>Melidonis, A</au><au>Xilomenos, A</au><au>Ioannidis, I</au><au>Kaltsas, G</au><au>Lanaras, L</au><au>Papas, S</au><au>Basagiannis, C</au><au>Kokkinos, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals</atitle><jtitle>Diabetes &amp; metabolism</jtitle><addtitle>Diabetes Metab</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>41</volume><issue>2</issue><spage>126</spage><epage>131</epage><pages>126-131</pages><issn>1262-3636</issn><eissn>1878-1780</eissn><abstract>Abstract Aim Hypoglycaemia is considered a factor contributing to morbidity and mortality in patients with diabetes. The aim of the present study was to examine the frequency, clinical characteristics, predisposing factors and outcomes of iatrogenic hypoglycaemia requiring medical assistance. Methods Eight hospitals participated in this prospective survey of documented iatrogenic hypoglycaemia at their emergency departments. Cases with type 2 diabetes (T2D) were compared with a control group, consisting of patients visiting the outpatients’ diabetes clinics of the same hospitals during the same time period. Results Median survey duration was 16.5 months, and 295 episodes of iatrogenic hypoglycaemia were recorded. Frequency varied across centres from 0.25 to 0.78 cases per 100 presenting patients. Most cases (90.8%) were observed in patients with T2D (mean age: 76.7 ± 10.1 years), while 8.1% of events were recorded in patients with type 1 diabetes (mean age: 42.7 ± 18.3 years). Total in-hospital mortality was 3.4%, and all involved patients with T2D. In T2D patients, advanced age (OR: 1.3 [1.20–1.45] for 5-year increase), use of sulphonylureas (OR: 4.0 [2.5–6.36]), use of insulin (OR: 2.35 [1.42–3.95]), lower estimated GFR (OR: 1.15 [1.07–1.23] at 10 mL/min) and number of comorbidities (OR: 1.74 [1.34–2.27]) were each independently associated with hypoglycaemia requiring medical assistance. Conclusion Hypoglycaemia requiring medical assistance in patients with diabetes is a moderately common condition seen in emergency departments and has a mortality rate of 3.4%. The majority of cases involve elderly individuals with T2D who are suffering from serious comorbidities and treated with insulin and/or sulphonylureas.</abstract><cop>France</cop><pub>Elsevier Masson SAS</pub><pmid>25468446</pmid><doi>10.1016/j.diabet.2014.10.006</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1262-3636
ispartof Diabetes & metabolism, 2015-04, Vol.41 (2), p.126-131
issn 1262-3636
1878-1780
language eng
recordid cdi_proquest_miscellaneous_1673078915
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Adult
Aged
Aged, 80 and over
Diabetes Mellitus, Type 1 - drug therapy
Diabetes Mellitus, Type 2 - drug therapy
Endocrinology & Metabolism
Female
Hospitalization
Humans
Hypoglycaemia
Hypoglycemia - chemically induced
Hypoglycemia - epidemiology
Hypoglycemia - therapy
Hypoglycemic Agents - adverse effects
Hypoglycemic Agents - therapeutic use
Insulin - adverse effects
Insulin - therapeutic use
Internal Medicine
Male
Middle Aged
Prevalence
Prospective Studies
Sulfonylurea Compounds - adverse effects
Sulfonylurea Compounds - therapeutic use
Tertiary Care Centers
Type 1 diabetes
Type 2 diabetes
Young Adult
title Hypoglycaemia requiring medical assistance in patients with diabetes: A prospective multicentre survey in tertiary hospitals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T16%3A04%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypoglycaemia%20requiring%20medical%20assistance%20in%20patients%20with%20diabetes:%20A%20prospective%20multicentre%20survey%20in%20tertiary%20hospitals&rft.jtitle=Diabetes%20&%20metabolism&rft.au=Liatis,%20S&rft.date=2015-04-01&rft.volume=41&rft.issue=2&rft.spage=126&rft.epage=131&rft.pages=126-131&rft.issn=1262-3636&rft.eissn=1878-1780&rft_id=info:doi/10.1016/j.diabet.2014.10.006&rft_dat=%3Cproquest_cross%3E1673078915%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1673078915&rft_id=info:pmid/25468446&rft_els_id=S1262363614001670&rfr_iscdi=true